{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "15083292",
  "DateCompleted": {
    "Year": "2005",
    "Month": "03",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2004",
    "Month": "04",
    "Day": "14"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0340-5354",
      "JournalIssue": {
        "Volume": "251",
        "Issue": "4",
        "PubDate": {
          "Year": "2004",
          "Month": "Apr"
        }
      },
      "Title": "Journal of neurology",
      "ISOAbbreviation": "J Neurol"
    },
    "ArticleTitle": "Drug-induced hyperthermia in Huntington's disease.",
    "Pagination": {
      "StartPage": "454",
      "EndPage": "457",
      "MedlinePgn": "454-7"
    },
    "Abstract": {
      "AbstractText": [
        "Until now, only three patients with Huntington's disease (HD) and a neuroleptic malignant syndrome (NMS) have been reported in the literature. We describe four cases with advanced stage Huntington's disease who within a period of one year developed drug-induced hyperthermia, either the neuroleptic malignant syndrome, or the serotonin syndrome. Possible contributing factors that may have been specific for HD patients could be identified and included advanced neurological disease with severe illness, occurrence in summer, with possible infectious disease, dehydration, and pre-existing extra-pyramidal signs that may mask incipient NMS/serotonin syndrome. Measures to avoid these potentially lifethreatening conditions are discussed."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Nursing Home Heemhof, Apeldoorn, The Netherlands."
          }
        ],
        "LastName": "Gaasbeek",
        "ForeName": "D",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Naarding",
        "ForeName": "P",
        "Initials": "P"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Stor",
        "ForeName": "T",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kremer",
        "ForeName": "H P H",
        "Initials": "HP"
      }
    ],
    "PublicationTypeList": [
      "Case Reports",
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Germany",
    "MedlineTA": "J Neurol",
    "NlmUniqueID": "0423161",
    "ISSNLinking": "0340-5354"
  },
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [
        "chemically induced",
        "diagnosis",
        "prevention & control"
      ],
      "DescriptorName": "Fever"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy",
        "physiopathology"
      ],
      "DescriptorName": "Huntington Disease"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [
        "diagnosis",
        "prevention & control"
      ],
      "DescriptorName": "Neuroleptic Malignant Syndrome"
    },
    {
      "QualifierName": [
        "diagnosis",
        "prevention & control"
      ],
      "DescriptorName": "Serotonin Syndrome"
    }
  ]
}